Accelerating Medicine Partnership

The Accelerating Medicines Partnership (AMP) is a new venture between the NIH, 10 biopharmaceutical companies and several non-profit organizations to transform the current model for developing new diagnostics and treatments by jointly identifying and validating promising biological targets of disease.

Accelerating Medicine Partnership

The U.S. government through the National Institutes of Health (NIH) has launched a public-private partnership to accelerate the development of life-saving drugs and to help identify new treatments and cures and help address today’s global public health challenges. The Accelerating Medicines Partnership (AMP) is cofounded by the NIH, ten leading pharmaceutical companies, and a number of nonprofit organizations and will invest $230 million over five years to support the large-scale characterization of the underlying pathology of Alzheimer's disease, type 2 diabetes, rheumatoid arthritis, and lupus.

Through this cross-sector partnership, which will be managed through the Foundation for the NIH (FNIH), NIH and industry partners are sharing expertise and resources through an integrated governance structure that enables the best informed contributions to science from all participants. A critical component of the partnership is that industry partners have agreed to make the AMP data and analyses publicly accessible to the broad biomedical community. These pilot projects will set the stage for broadening AMP to other diseases and conditions. The AMP includes: the U.S. Food and Drug Administration, the NIH, AbbVie, Biogen Idec, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Merck, Pfizer, Sanofi, Takeda and eight non-profit groups.


  • U.S. Food and Drug Administration (FDA)

    Staff size: 5001-10,000

    The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s...

  • National Institutes of Health (NIH) - United States

    Institute, Funding Agencies
    United States | Staff size: 10,000+

    The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency—making important medical discoveries that...

  • AbbVie

    Service Providers
    United States | Staff size: 10,000+

    AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. AbbVie combines the focus and passion of a leading-edge biotech with the expertise...

  • Biogen Idec

    Service Providers
    Staff size: 5001-10,000

    Biogen Idec is a biotechnology leader that discovers, develops and delivers medicines to improve the lives of patients. As a company, Biogen Idec recognizes that cutting-edge science and...

  • Bristol-Myers Squibb

    Service Providers
    Staff size: 10,000+

    Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail against serious diseases. Around the...

  • GlaxoSmithKline (GSK)

    Goods Supplier
    United Kingdom | Staff size: 10,000+

    We are a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Our products are used by millions of people around the world,...

  • Johnson & Johnson

    Service Providers, Goods Supplier
    United States | Staff size: 10,000+

    At Johnson & Johnson we are committed to:

    • Building healthy communities through innovative and impactful healthcare solutions and...
  • Eli Lilly and Company

    Independent/None, Goods Supplier
    United States | Staff size: 10,000+

    Eli Lilly and Company, incorporated in 1901, discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products. The Company also has an animal health...

  • Merck

    Service Providers, Goods Supplier
    United States | Staff size: 10,000+

    Merck is an innovative, global healthcare leader that is committed to improving health and well-being around the world. At Merck, they're applying their global reach, financial strength and...

  • Pfizer

    Goods Supplier, Institute
    United States | Staff size: 1001-5000

    At Pfizer, they apply science and their global resources to bring therapies to people that extend and significantly improve their lives.

    They strive to set the standard for quality,...

  • Sanofi

    Goods Supplier
    Canada | Staff size: Unknown

    Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the research and development,...

  • Takeda

    Service Providers
    Japan | Staff size: 5001-10,000

    For more than 230 years, Takeda has been serving society with innovative medicines, helping patients reclaim valuable moments of life from illness. Now, with new healthcare solutions from...

  • Geoffrey Beene Foundation

    Staff size: Unknown

    Geoffrey Beene designs are always in sync with the future and in touch with how we live, work and play. Woven into every new garment and accessory is our promise and pledge to support a...

More Resources

Key Information

  • Start Date 2014
  • End Date 2018
  • ValueUSD 230 Million